Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | International Braz J Urol (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000300489 |
Resumo: | ABSTRACT Purpose To examine the safety and efficacy of hyperbaric oxygen as the primary and sole treatment for severe radiation-induced haemorrhagic cystitis. Materials and methods Hyperbaric oxygen was prospectively applied as primary treatment in 38 patients with severe radiation cystitis. Our primary endpoint was the incidence of complete and partial response to treatment, while the secondary endpoints included the duration of response, the correlation of treatment success-rate to the interval between the onset of haematuria and initiation of therapy, blood transfusion need and total radiation dose, the number of sessions to success, the avoidance of surgery and the overall survival. Results All patients completed therapy without complications with a mean follow-up of 29.33 months. Median number of sessions needed was 33. Complete and partial response rate was 86.8% and 13.2%, respectively. All 33 patients with complete response received therapy within 6 months of the haematuria onset. One patient needed cystectomy, while 33 patients were alive at the end of follow-up. Conclusions Our study suggests the early primary use of hyperbaric oxygen for radiation-induced severe cystitis as an effective and safe treatment option. |
id |
SBU-1_48ecbb4d301fecf5b04031b79b3e6479 |
---|---|
oai_identifier_str |
oai:scielo:S1677-55382017000300489 |
network_acronym_str |
SBU-1 |
network_name_str |
International Braz J Urol (Online) |
repository_id_str |
|
spelling |
Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitisUrinary BladderCystitisHematuriaOxygen Inhalation TherapyABSTRACT Purpose To examine the safety and efficacy of hyperbaric oxygen as the primary and sole treatment for severe radiation-induced haemorrhagic cystitis. Materials and methods Hyperbaric oxygen was prospectively applied as primary treatment in 38 patients with severe radiation cystitis. Our primary endpoint was the incidence of complete and partial response to treatment, while the secondary endpoints included the duration of response, the correlation of treatment success-rate to the interval between the onset of haematuria and initiation of therapy, blood transfusion need and total radiation dose, the number of sessions to success, the avoidance of surgery and the overall survival. Results All patients completed therapy without complications with a mean follow-up of 29.33 months. Median number of sessions needed was 33. Complete and partial response rate was 86.8% and 13.2%, respectively. All 33 patients with complete response received therapy within 6 months of the haematuria onset. One patient needed cystectomy, while 33 patients were alive at the end of follow-up. Conclusions Our study suggests the early primary use of hyperbaric oxygen for radiation-induced severe cystitis as an effective and safe treatment option.Sociedade Brasileira de Urologia2017-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000300489International braz j urol v.43 n.3 2017reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/s1677-5538.ibju.2016.0451info:eu-repo/semantics/openAccessDellis,AthanasiosPapatsoris,AthanasiosKalentzos,VasileiosDeliveliotis,CharalambosSkolarikos,Andreaseng2017-05-31T00:00:00Zoai:scielo:S1677-55382017000300489Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2017-05-31T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false |
dc.title.none.fl_str_mv |
Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis |
title |
Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis |
spellingShingle |
Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis Dellis,Athanasios Urinary Bladder Cystitis Hematuria Oxygen Inhalation Therapy |
title_short |
Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis |
title_full |
Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis |
title_fullStr |
Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis |
title_full_unstemmed |
Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis |
title_sort |
Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis |
author |
Dellis,Athanasios |
author_facet |
Dellis,Athanasios Papatsoris,Athanasios Kalentzos,Vasileios Deliveliotis,Charalambos Skolarikos,Andreas |
author_role |
author |
author2 |
Papatsoris,Athanasios Kalentzos,Vasileios Deliveliotis,Charalambos Skolarikos,Andreas |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Dellis,Athanasios Papatsoris,Athanasios Kalentzos,Vasileios Deliveliotis,Charalambos Skolarikos,Andreas |
dc.subject.por.fl_str_mv |
Urinary Bladder Cystitis Hematuria Oxygen Inhalation Therapy |
topic |
Urinary Bladder Cystitis Hematuria Oxygen Inhalation Therapy |
description |
ABSTRACT Purpose To examine the safety and efficacy of hyperbaric oxygen as the primary and sole treatment for severe radiation-induced haemorrhagic cystitis. Materials and methods Hyperbaric oxygen was prospectively applied as primary treatment in 38 patients with severe radiation cystitis. Our primary endpoint was the incidence of complete and partial response to treatment, while the secondary endpoints included the duration of response, the correlation of treatment success-rate to the interval between the onset of haematuria and initiation of therapy, blood transfusion need and total radiation dose, the number of sessions to success, the avoidance of surgery and the overall survival. Results All patients completed therapy without complications with a mean follow-up of 29.33 months. Median number of sessions needed was 33. Complete and partial response rate was 86.8% and 13.2%, respectively. All 33 patients with complete response received therapy within 6 months of the haematuria onset. One patient needed cystectomy, while 33 patients were alive at the end of follow-up. Conclusions Our study suggests the early primary use of hyperbaric oxygen for radiation-induced severe cystitis as an effective and safe treatment option. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000300489 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000300489 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/s1677-5538.ibju.2016.0451 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Urologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Urologia |
dc.source.none.fl_str_mv |
International braz j urol v.43 n.3 2017 reponame:International Braz J Urol (Online) instname:Sociedade Brasileira de Urologia (SBU) instacron:SBU |
instname_str |
Sociedade Brasileira de Urologia (SBU) |
instacron_str |
SBU |
institution |
SBU |
reponame_str |
International Braz J Urol (Online) |
collection |
International Braz J Urol (Online) |
repository.name.fl_str_mv |
International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU) |
repository.mail.fl_str_mv |
||brazjurol@brazjurol.com.br |
_version_ |
1750318075468578816 |